High Percentage of CD34-positive Cells in Autologous AML Peripheral Blood Stem Cell Products Reflects Inadequate in Vivo Purging and Low Chemotherapeutic Toxicity in a Subgroup of Patients With Poor Clinical Outcome
Leukemia - United Kingdom
doi 10.1038/sj.leu.2402781
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2003
Authors
Publisher
Springer Science and Business Media LLC